Kestra Private Wealth Services’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$511K Sell
8,124
-957
-11% -$66.9K 0.01% 1220
2026
Q1
$685K Buy
9,081
+405
+5% +$28.9K 0.01% 1040
2025
Q4
$535K Buy
8,676
+223
+3% +$13.1K 0.01% 1127
2025
Q3
$496K Buy
8,453
+20
+0.2% +$1.17K 0.01% 1097
2025
Q2
$491K Sell
8,433
-1,277
-13% -$72.2K 0.01% 1049
2025
Q1
$482K Buy
9,710
+1,500
+18% +$76.7K 0.01% 972
2024
Q4
$367K Sell
8,210
-864
-10% -$41K 0.01% 1056
2024
Q3
$436K Sell
9,074
-4,795
-35% -$231K 0.01% 929
2024
Q2
$706K Buy
13,869
+3,203
+30% +$175K 0.01% 698
2024
Q1
$579K Buy
10,666
+671
+7% +$35K 0.01% 739
2023
Q4
$563K Buy
9,995
+1,311
+15% +$74.1K 0.01% 689
2023
Q3
$536K Buy
8,684
+493
+6% +$31.2K 0.02% 639
2023
Q2
$484K Sell
8,191
-5,503
-40% -$350K 0.02% 653
2023
Q1
$1.01M Buy
+13,694
New +$1.06M 0.04% 403

Other funds holding NTR

Kestra Private Wealth Services's NTR Position: Q2 2026 in Review

Kestra Private Wealth Services reduced its Nutrien (NTR) stake by 11% in Q2 2026, selling an estimated $66.9K and leaving 8,124 shares worth $511K. The position accounts for 0.01% of the portfolio, ranked #1220.

Kestra Private Wealth Services first reported a position in NTR in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.01M in Q1 2023. 734 funds tracked by Wall St. Rank hold NTR as of Q2 2026.

  • Kestra Private Wealth Services held 8,124 shares of Nutrien worth $511K as of Q2 2026.
  • Kestra Private Wealth Services sold 957 Nutrien shares in Q2 2026, an estimated $66.9K.
  • Nutrien made up 0.01% of Kestra Private Wealth Services's portfolio in Q2 2026, its #1220 holding.
  • Kestra Private Wealth Services first reported a position in Nutrien in Q1 2023 and has held it in 14 quarters since.
  • Kestra Private Wealth Services's Nutrien position peaked at $1.01M in Q1 2023.
  • 734 funds tracked by Wall St. Rank held Nutrien as of Q2 2026.

Based on Kestra Private Wealth Services's 13F filing for Q2 2026, filed 28 Jul 2026.